Table 3a.
Measurement | n | Group | r | p-value |
---|---|---|---|---|
Day 90 % LPS-specific IgA BM | 33 | Vaccine | −0.39 | 0.02 |
% LPS-specific IgA BM: Ratio of Day 90 to Day 0 | 33 | Vaccine | −0.56 | < 0.001 |
Day 90 % LPS-specific IgA BM | 33 | Placebo | −0.17 | 0.33 |
% LPS-specific IgA BM: Ratio of Day 90 to Day 0 | 33 | Placebo | 0.02 | 0.92 |